Increasing incidence of myelodysplastic syndromes: real or fictitious?

[1]  T Hamblin,et al.  International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.

[2]  T. Petrella,et al.  Epidemiological characteristics of myelodysplastic syndrome in a well-defined French population. , 1996, British Journal of Cancer.

[3]  J. Karp,et al.  The secondary leukemias: challenges and research directions. , 1996, Journal of the National Cancer Institute.

[4]  S. Paydaş,et al.  Younger age observation in myelodysplastic syndrome. , 1996, Leukemia research.

[5]  C. Lorthois,et al.  Exposure to occupational and environmental factors in myelodysplastic syndromes. Preliminary results of a case-control study. , 1995, Leukemia.

[6]  M. Carlsson,et al.  Incidence of myelodysplastic syndromes in a Swedish population , 1995, European journal of haematology.

[7]  D. A. Stafford,et al.  Occupational and environmental exposures and myelodysplasia: a case-control study. , 1995, Leukemia research.

[8]  N. Gattermann,et al.  Epidemiological and etiological aspects of myelodysplastic syndromes. , 1995, Leukemia & lymphoma.

[9]  G. Verhoef.  Clinicomorphological features of myelodysplastic syndromes , 1994 .

[10]  D. Oscier,et al.  Establishing the incidence of myelodysplastic syndrome. , 1994, British journal of haematology.

[11]  M. Szklo,et al.  Hair dye use and other risk factors for leukemia and pre-leukemia: a case-control study. Italian Leukemia Study Group. , 1994, American journal of epidemiology.

[12]  J. Fraumeni,et al.  Hematopoietic malignancies and related disorders among benzene-exposed workers in China. , 1994, Leukemia & lymphoma.

[13]  N. Gattermann,et al.  Age‐related incidence and other epidemiological aspects of myelodysplastic syndromes , 1992, British journal of haematology.

[14]  P. Reizenstein,et al.  What is MDS , 1992 .

[15]  M. Sanz,et al.  Prognostic factors in myelodysplastic syndromes. , 1992, Leukemia research.

[16]  R. Luksch,et al.  Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico‐pathological entity , 1991, British journal of haematology.

[17]  P. Reizenstein,et al.  Increasing prevalence of the myelodysplastic syndrome. An international Delphi study. , 1991, Anticancer research.

[18]  M. Frank-Stromborg,et al.  Changing demographics in the united states: Implications for health professionals , 1991, Cancer.

[19]  Terry J. Hamblin,et al.  Leukaemia and Lymphoma—an atlas of distribution within areas of England and Wales, 1984–1988 , 1990 .

[20]  F. Alexander,et al.  Cancer registration of leukaemias and lymphomas: results of a comparison with a specialist registry. , 1989, Community medicine.

[21]  J. Faivre,et al.  Haematopoietic malignancies in Côte d'Or (France): a population based study. , 1986, British Journal of Cancer.

[22]  D. Galton.  The myelodysplastic syndromes. , 1987, Clinical and laboratory haematology.

[23]  H. Gralnick,et al.  Proposals for the classification of the myelodysplastic syndromes , 1982, British journal of haematology.

[24]  M. Saarni,et al.  Preleukemia: The hematologie syndrome preceding acute leukemia , 1973 .